Video Experimental Relacionado
Updated: Jul 9, 2026
05:08
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
La hemocromatosis es una cromatosis
1University Hospital, London, ON, Canada. padams@uwo.ca
Lancet (London, England)
|December 7, 2007
Resumen
La hemocromatosis hereditaria es un trastorno genético común. Si bien algunos desarrollan una enfermedad hepática grave, muchos portadores de la mutación C282Y permanecen asintomáticos, lo que destaca la necesidad de un monitoreo y tratamiento personalizados.
Área de la Ciencia:
- Genética La genética.
- Hepatología Hepatología.
- Medicina interna es la medicina interna de las enfermedades.
Sus antecedentes:
- La hemocromatosis hereditaria, vinculada al gen HFE descubierto en 1996, es un trastorno genético prevalente.
- La presentación clínica varía ampliamente, desde individuos asintomáticos hasta cirrosis severa con alta mortalidad.
- El cribado de la población ha identificado numerosos homocigotos asintomáticos de la mutación C282Y que no desarrollan sobrecarga de hierro.
Objetivo del estudio:
- Para resumir los avances recientes en la comprensión de la hemocromatosis hereditaria.
- Para resaltar la penetración variable de la mutación C282Y.
- Para discutir los marcadores diagnósticos y los resultados terapéuticos.
Principales métodos:
- Revisión de la literatura existente sobre la hemocromatosis hereditaria.
- Análisis de los datos de cribado de la población para los portadores de la mutación C282Y.
- Evaluación de pruebas de diagnóstico como la saturación de transferrina y la ferritina sérica.
- Evaluación de la eficacia de la terapia de flebotomía.
Principales resultados:
- Muchos individuos con la mutación C282Y permanecen asintomáticos a pesar de la homocigosidad.
- La saturación de transferrina y la ferritina sérica son indicadores de diagnóstico útiles.
- El tratamiento con flebotomía ha demostrado ser eficaz para mejorar la fibrosis hepática.
- Las pruebas genéticas para la hemocromatosis hereditaria son generalmente bien aceptadas.
Conclusiones:
- La hemocromatosis hereditaria exhibe una penetración clínica variable.
- El diagnóstico temprano y el monitoreo son cruciales para el manejo del trastorno.
- La flebotomía sigue siendo una intervención terapéutica clave para las personas afectadas.
Videos de Conceptos Relacionados
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:16Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...